Prevention and treatment of infectious complications in haematooncology

Česká verzia

Authors: M. Kouba; M. Lukášová
Authors place of work: Ústav hematologie a krevní transfuze Praha, ředitel prof. MUDr. Marek Trněný, CSc.
Published in the journal: Vnitř Lék 2012; 58(Suppl 2): 56-60
Category:

Summary

Infectious complications are besides bleeding the most frequent cause of morbidity and mortality in otherwise succesful anti--leukemic therapy. Use of antimicrobial drugs and measures accompany the progress of the anti-leukemic therapy. We shortly summarize the literature on antimicrobial supportive care and the story of this field in the Institute of Hematology and Blood Transfusion, Prague. Our current diagnostic, prophylactic and therapeutic strategies are mentioned finally.

Key words:
antibiotics – antimycotics – infection – leukemia – febrile neutropenia

Zdroje

1. Bodey GP, Buckley M, Sathe YS et al. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64: 328–340.

2. Freireich EJ. Supportive care for patients with blood disorders. Br J Haematol 2000; 111: 68–77.

3. Freireich EJ, Levin RH, Whang J et al. The function and fate of transfused leukocytes from donors with chronic myelocytic leukemia in leukopenic recipients. Ann NY Acad Sci 1964; 113: 1081–1089.

4. Hersh EM, Bodey GP, Nies BA et al. Causes of death in acute leukemia: a ten-year study of 414 patients from 1954–1963. JAMA 1965; 193: 105–109.

5. Bodey GP. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Fever and neutropenia: the early years. J Antimicrob Chemother 2009; 63 (Suppl 1): i3–i13.

6. Schimpff SC, Young VM, Greene WH et al. Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens. Ann Intern Med 1972; 77: 707–714.

7. Pizzo PA, Robichaud KJ, Gill FA et al. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982; 72: 101–111.

8. Herbrecht R, Denning DW, Patterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408–415.

9. Ascioglu S, Rex JH, de Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7–14.

10. Lukasova M, Chudomel V, Jezkova Z. Experience in the treatment of acute leukemia at the Intensive Hematology Care Unit. Vnitr Lek 1980; 26: 1059–1065.

11. Lukasova M, Mirejovsky P, Fragner P et al. Mucormycosis in hematologic diseases. Vnitr Lek 1988; 34: 330–339.

12. Lukasova M, Sedlackova M, Libansky J. Occurrence of infectious complications during therapy for acute leukemia. Vnitr Lek 1979; 25: 542–549.

13. Hubacek P, Maalouf J, Zajickova M et al. Failure of multiple antivirals to affect high HHV-6 DNAaemia resulting from viral chromosomal integration in case of severe aplastic anaemia. Haematologica 2007; 92: e98–e100.